Candesant Biomedical, Inc. — Form D
Candesant Biomedical, Inc. of Nashville, TN, a company, filed a Form D exempt-offering notice with the SEC on 2023-06-06. The offering totals $35.4M, of which $35.4M was reported sold. Industry: Other Health Care.
Offering
- Filed: 2023-06-06
- Form: D
- Accession: 0001567619-23-006301
- Industry: Other Health Care
- Exemptions: 06b
- Total offering: $35.4M
- Amount sold: $35.4M
- Investors: 59
- Date of first sale: 2022-04-12
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-483421
Issuer
- Name: Candesant Biomedical, Inc.
- CIK: 0001802148
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2015
- Address: 1718 Church Street # 1458, Nashville, TN, 37203
- Phone: (415) 726-4888
Officers, directors & promoters (11)
| Name | Role | Location |
|---|
| Samara L Braunstein | Director | Nashville, TN |
| Brad L Hauser | Director | Nashville, TN |
| Niquette L Hunt | Director | Nashville, TN |
| Michael L Kane | Director | Nashville, TN |
| Karen L Long | Director | Nashville, TN |
| Eileen L McGuire | Director | Nashville, TN |
| Niquette L Hunt | Executive Officer | Nashville, TN |
| Mary Beth L Kreissler | Executive Officer | Nashville, TN |
| Amy L Schulman | Director | San Francisco, CA |
| Robert L Grove, Ph.D. | Director | San Francisco, CA |
| Michael A C Kane, M.D. | Director | San Francisco, CA |
Other filings by this issuer (1)
More